Search - tctmd.com

Displaying 81 - 100 of 211

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT Abstracts 2024

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Presenter: Daniel Bensimhon

March 05, 2024

Presentation THT 2024

Leveraging Remote Patient Monitoring to Implement GDMT

Presenter: Marat Fudim

March 05, 2024

Presentation THT 2024

CCM®- Don’t Wait

Presenter: Rami Kahwash

March 05, 2024

Presentation THT 2024

Update on the Integra-D Trial

Presenter: Niraj Varma

March 05, 2024

Presentation THT 2024

Challenges and Opportunities with Contemporary GDMT

Presenter: James Thomas Heywood

March 05, 2024

Presentation THT 2024

Cardiac Recovery in Response to GDMT

Presenter: Andreas Kalogeropoulos

March 04, 2024

Presentation THT 2024

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Presenter: Shmuel Chen

March 04, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Todd Neale

December 29, 2023

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Caitlin E. Cox

November 14, 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

Presentation TCT 2023

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Presenter: Clyde Yancy

October 24, 2023

Presentation TCT 2023

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

Presenter: JoAnn Lindenfeld

October 24, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

Advertisement

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Leveraging Remote Patient Monitoring to Implement GDMT

CCM®- Don’t Wait

Update on the Integra-D Trial

Challenges and Opportunities with Contemporary GDMT

Cardiac Recovery in Response to GDMT

A Challenging TAVR Case: Severe AS and Severe LV Dysfunction (Role of GDMT and MCS)

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

GDMT Rates Low in HFrEF, Particularly in Women

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?

Will Advances in GDMT Reduce Need for Mitral TEER in Secondary MR?

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content